Abstract 1726: NEOK002 (ABL209): Redesigning an EGFRxMUC1 bispecific TOP1i ADC with promising anti-tumor activity and enhanced therapeutic window
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institution: ABL Bio (South Korea)
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148769693
Cites:
Cited by:
Related to:
